Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21610270 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant (Auditor)
Conditions: Carotid Artery Plaque;   Arteriosclerosis;   Obesity;   Metabolic Syndrome X
Interventions: Drug: rimonabant (SR141716);   Drug: placebo

Indicates status has not been verified in more than two years